Characterization and evaluation of the antitumour activity of a dual-targeting monoclonal antibody against claudin-3 and claudin-4.

Mariko Kato‐Nakano, Masayo Suzuki, Shinobu Kawamoto, Akiko Furuya, So Ohta, Kazuyasu Nakamura, Hiroshi Ando

PubMed · 2010 · 33 citations · 13 references

Abstract

A dual-targeting monoclonal antibody against CLDN3 and CLDN4 is a promising strategy for cancer immunotherapy.

References

13